Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BSX
MRNA
Add up to 3 more stocks
BSX
Boston Scientific Corporation
-1.46%
$42.60-0.63Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$63.32B
52W Range
$41.94 - $105.65
MRNA
Moderna, Inc.
+0.57%
$190.01+1.07Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$75.39B
52W Range
$22.28 - $208.90
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 17.32 | N/A |
| Forward P/E | 13.03 | N/A |
| PEG Ratio | 0.58 | N/A |
| P/B Ratio | 2.54 | 11.15 |
| P/S Ratio | 3.02 | 33.84 |
| P/FCF Ratio | 17.47 | N/A |
| EV/EBITDA | 13.01 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 71.2% | 55.4% |
| Operating Margin | 21.5% | -158.1% |
| Net Margin | 17.5% | -141.4% |
| ROE | 14.7% | -46.6% |
| ROA | 8.1% | -28.8% |
| ROIC | 10.6% | -39.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.24 | 2.29 |
| Quick Ratio | 0.74 | 2.18 |
| Debt/Equity | 0.51 | 0.19 |
| Interest Coverage | 11.38 | -307.40 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.